Fengming Yi
Impact in
- Hepatology top 10%
- Hepatocellular Carcinoma Treatment and Prognosis
-
- Pancreatic and Hepatic Oncology Research
Papers in
-
- Hepatocellular Carcinoma Treatment and Prognosis 7
- Oncology 11
- Lung Cancer Research Studies 3
- Colorectal Cancer Surgical Treatments 2
- Co-authors
- Bing Xia (9 shared papers)Wenxiong Zhang (24 shared papers)Jie Zhao (3 shared papers)Feng Zhou (4 shared papers)Yiping Wei (20 shared papers)Zhifen Chen (1 shared paper)Youqing Zhu (1 shared paper)Long Feng (9 shared papers)
In The Last Decade
Fengming Yi
52 papers receiving 930 citations
Peers
Comparison fields: 5 of 90
- Hepatology 75
- Oncology 179
- Genetics 177
- Surgery 231
- Cancer Research 77
Countries citing papers authored by Fengming Yi
This map shows the geographic impact of Fengming Yi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fengming Yi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fengming Yi more than expected).
Fields of papers citing papers by Fengming Yi
This network shows the impact of papers produced by Fengming Yi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fengming Yi. The network helps show where Fengming Yi may publish in the future.
Co-authors
The 25 scholars most cited alongside Fengming Yi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 56 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 139 | |
| 2 | 2013 | 109 | |
| 3 | 2014 | 75 | |
| 4 | Inhibition of histone deacetylase 11 promotes human liver cancer cell apoptosis. | 2019 | 41 |
| 5 | 2013 | 38 | |
| 6 | 2010 | 33 | |
| 7 | 2023 | 31 | |
| 8 | 2019 | 30 | |
| 9 | 2013 | 28 | |
| 10 | 2013 | 28 | |
| 11 | 2019 | 24 | |
| 12 | 2025 | 23 | |
| 13 | 2019 | 22 | |
| 14 | 2020 | 21 | |
| 15 | 2020 | 20 | |
| 16 | 2019 | 19 | |
| 17 | 2021 | 17 | |
| 18 | 2012 | 17 | |
| 19 | 2014 | 16 | |
| 20 | 2020 | 15 |
About Fengming Yi
Fengming Yi is a scholar working on Hepatology, Oncology, Pulmonary and Respiratory Medicine, Genetics and Surgery, having authored 56 papers that have together received 947 indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (7 papers), Inflammatory Bowel Disease (7 papers), Gastric Cancer Management and Outcomes (5 papers), Lung Cancer Research Studies (3 papers), Epigenetics and DNA Methylation (3 papers), Lung Cancer Treatments and Mutations (3 papers), Colorectal Cancer Surgical Treatments (2 papers) and Cancer, Hypoxia, and Metabolism (2 papers). The work is most often cited by research in Hepatology (75 citations), Oncology (179 citations), Genetics (177 citations), Surgery (231 citations) and Cancer Research (77 citations). Fengming Yi has collaborated with scholars based in China, Hong Kong and Australia. Frequent co-authors include Bing Xia, Wenxiong Zhang, Jie Zhao, Feng Zhou, Yiping Wei, Zhifen Chen, Youqing Zhu, Long Feng, Sha Huang and Jianbing Wu. Their work appears in journals such as World Journal of Surgical Oncology, Medicine, Frontiers in Oncology, Chemotherapy and Cancer Chemotherapy and Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.